Compounds > ranolazine
Page last updated: 2024-08-24

ranolazine and Cardiomyopathies

ranolazine has been researched along with Cardiomyopathies in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Canovi, M; Fumagalli, F; Gobbi, M; Latini, R; Letizia, T; Li, Y; Masson, S; Novelli, D; Ristagno, G; Rocchetti, M; Russo, I; Staszewsky, L; Veglianese, P; Zaza, A1
Kaliebe, J; Murdock, DK; Overton, N1
Stone, PH1
Freudenberger, R; Levin, V; Martinez, MW; Nanda, S1
Dey, T; Martinez, MW; Nanda, S1

Reviews

1 review(s) available for ranolazine and Cardiomyopathies

ArticleYear
Ranolazine: new paradigm for management of myocardial ischemia, myocardial dysfunction, and arrhythmias.
    Cardiology clinics, 2008, Volume: 26, Issue:4

    Topics: Acetanilides; Angina Pectoris; Animals; Arrhythmias, Cardiac; Cardiomyopathies; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Ischemia; Piperazines; Ranolazine

2008

Other Studies

4 other study(ies) available for ranolazine and Cardiomyopathies

ArticleYear
Ranolazine ameliorates postresuscitation electrical instability and myocardial dysfunction and improves survival with good neurologic recovery in a rat model of cardiac arrest.
    Heart rhythm, 2014, Volume: 11, Issue:9

    Topics: Acetanilides; Animals; Cardiomyopathies; Cardiopulmonary Resuscitation; Central Nervous System; Disease Models, Animal; Enzyme Inhibitors; Heart Arrest; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Treatment Outcome; Ventricular Dysfunction, Left

2014
Ranolozine-induced suppression of ventricular tachycardia in a patient with nonischemic cardiomyopathy: a case report.
    Pacing and clinical electrophysiology : PACE, 2008, Volume: 31, Issue:6

    Topics: Acetanilides; Aged; Cardiomyopathies; Enzyme Inhibitors; Humans; Male; Myocardial Ischemia; Piperazines; Ranolazine; Tachycardia, Ventricular; Treatment Outcome

2008
Ranolazine--treatment of ventricular tachycardia and symptomatic ventricular premature beats in ischemic cardiomyopathy.
    Pacing and clinical electrophysiology : PACE, 2010, Volume: 33, Issue:12

    Topics: Acetanilides; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Coronary Artery Bypass; Coronary Artery Disease; Death, Sudden, Cardiac; Defibrillators, Implantable; Dyspnea; Enzyme Inhibitors; Humans; Male; Middle Aged; Piperazines; Ranolazine; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes

2010
Ranolazine is effective for acute or chronic ischemic dysfunction with heart failure.
    Journal of the American College of Cardiology, 2010, Aug-31, Volume: 56, Issue:10

    Topics: Acetanilides; Cardiomyopathies; Enzyme Inhibitors; Heart Failure; Humans; Myocardial Ischemia; Piperazines; Ranolazine

2010